194 related articles for article (PubMed ID: 23340221)
1. Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin.
Antunes Wilhelm E; Ricardo Jesse C; Folharini Bortolatto C; Wayne Nogueira C
Eur J Pharmacol; 2013 Feb; 701(1-3):65-72. PubMed ID: 23340221
[TBL] [Abstract][Full Text] [Related]
2. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
3. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
Pérez-Severiano F; Rodríguez-Pérez M; Pedraza-Chaverrí J; Maldonado PD; Medina-Campos ON; Ortíz-Plata A; Sánchez-García A; Villeda-Hernández J; Galván-Arzate S; Aguilera P; Santamaría A
Neurochem Int; 2004 Dec; 45(8):1175-83. PubMed ID: 15380627
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain.
Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
Behav Brain Res; 2014 Sep; 271():316-24. PubMed ID: 24959861
[TBL] [Abstract][Full Text] [Related]
5. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
Verma MK; Goel R; Nandakumar K; Nemmani KVS
Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
[TBL] [Abstract][Full Text] [Related]
6. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Ryu JK; Kim SU; McLarnon JG
Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
[TBL] [Abstract][Full Text] [Related]
7. Melatonin neutralizes neurotoxicity induced by quinolinic acid in brain tissue culture.
Vega-Naredo I; Poeggeler B; Sierra-Sánchez V; Caballero B; Tomás-Zapico C; Alvarez-García O; Tolivia D; Rodríguez-Colunga MJ; Coto-Montes A
J Pineal Res; 2005 Oct; 39(3):266-75. PubMed ID: 16150107
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats.
Kalonia H; Kumar P; Kumar A
Brain Res; 2011 Feb; 1372():115-26. PubMed ID: 21112316
[TBL] [Abstract][Full Text] [Related]
9. Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.
Kalonia H; Kumar P; Kumar A
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):607-15. PubMed ID: 21237233
[TBL] [Abstract][Full Text] [Related]
10. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
Kalonia H; Kumar P; Nehru B; Kumar A
Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
Maldonado PD; Molina-Jijón E; Villeda-Hernández J; Galván-Arzate S; Santamaría A; Pedraza-Chaverrí J
J Neurosci Res; 2010 Feb; 88(3):620-9. PubMed ID: 19795371
[TBL] [Abstract][Full Text] [Related]
14. Sub-chronic copper pretreatment reduces oxidative damage in an experimental Huntington's disease model.
Martínez-Lazcano JC; Montes S; Sánchez-Mendoza MA; Rodríguez-Páez L; Pérez-Neri I; Boll MC; Campos-Arroyo HD; Ríos C; Pérez-Severiano F
Biol Trace Elem Res; 2014 Dec; 162(1-3):211-8. PubMed ID: 25319005
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
Kalonia H; Kumar P; Kumar A; Nehru B
Neuroscience; 2010 Nov; 171(1):284-99. PubMed ID: 20813166
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease.
Túnez I; Montilla P; Del Carmen Muñoz M; Feijóo M; Salcedo M
J Pineal Res; 2004 Nov; 37(4):252-6. PubMed ID: 15485551
[TBL] [Abstract][Full Text] [Related]
18. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats.
Kalonia H; Kumar P; Kumar A
Behav Brain Res; 2011 Jan; 216(1):220-8. PubMed ID: 20696189
[TBL] [Abstract][Full Text] [Related]
19. An in vitro approach to assess the neurotoxicity of valproic acid-induced oxidative stress in cerebellum and cerebral cortex of young rats.
Chaudhary S; Parvez S
Neuroscience; 2012 Dec; 225():258-68. PubMed ID: 22960313
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats.
Kalonia H; Kumar P; Kumar A; Nehru B
Neurotoxicology; 2010 Mar; 31(2):195-203. PubMed ID: 20043943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
